Hesperos, Inc., a leader in human biology modeling for drug development through its Human-on-a-Chip® technology, is excited to announce the appointment of Lawrence (Larry) Florin as Chief Executive Officer. With…
GE HealthCare (Nasdaq: GEHC) has introduced CareIntellect for Oncology, a new cloud-based application that consolidates multi-modal patient data from various systems into a single, streamlined view. Utilizing generative AI, the…
MedTech Innovator (MTI), the leading accelerator for medical technology companies, has announced that Samay is the 2024 Grand Prize Winner, receiving $350,000 in non-dilutive funding. Based in Mountain View, California,…
CareDx, Inc. (Nasdaq: CDNA), known as The Transplant Company™, announced today new data and product enhancements to be presented at the 50th annual meeting of the American Society for Histocompatibility…
Seaport Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative neuropsychiatric medicines, has successfully closed an oversubscribed $225 million Series B financing round. The round was led by General Atlantic,…
Select Medical Corporation and SSM Health have announced a joint venture to establish the SSM Health Rehabilitation Hospital – Oklahoma City, a 50-bed inpatient rehabilitation facility located at 700 NW…
Medibank has announced its role as the official health partner of 36 Months, reinforcing its dedication to enhancing mental health in Australia. 36 Months is a social change initiative advocating…
GE HealthCare (Nasdaq: GEHC), the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation (CAFF) have joined forces to introduce a new philanthropic initiative called Powering Milwaukee Forward. This program…
Evidation, a leader in measuring and enhancing everyday health, has announced a long-term partnership with 1upHealth, a top provider of FHIR® platform solutions for claims and clinical data interoperability. This…
Luminate Health, a leader in healthcare technology for the clinical laboratory and diagnostics sector, is achieving remarkable success with its Direct-to-Consumer (DTC) lab testing platform. This innovative service allows commercial…
PursueCare, a leader in virtual addiction treatment, has announced the launch of RESET® and RESET-O®, the first FDA-authorized prescription digital therapeutics for substance use disorder (SUD) and opioid use disorder…
Siemens Healthineers has announced a new prognostic claim for its Atellica IM High-Sensitivity Troponin I (TnIH) test, significantly enhancing care for at-risk cardiac patients in the U.S. This straightforward blood…